Beyond Anti-VEGF: The Emerging Durability Landscape
Lejla Vajzovic, MD, FASRS
Szilard Kiss, MD
Gene Therapy for nAMD: Focus on Future Readiness
Carl D. Regillo, MD, FACS, FASRS
Unmet Needs in nAMD in 2026
How Gene Therapy Is Designed to Work in Retinal Disease
Retinas at Risk: Real-World Cases in High Disease Activity and Adherence Challenges
Interpreting Gene Therapy Data With Confidence
Adverse Event Mitigation in Gene Therapy for nAMD
Gene Therapy for nAMD: Navigating the Next Era of Durable Retinal Treatment
Geographic Atrophy: A Personalized Approach
Charles Turck, PharmD, BCPS, BCCCP
Jonathan Jonisch, MD
Novel Approaches in Early and Intermediate AMD: A Mechanistic Deep Dive
Diana V. Do, MD
Janis T. Eells, Ph.D.
David Boyer, MD
Eleonora Lad, MD, PhD
Marion R. Munk, MD, PhD
Redefining Durability in nAMD: The Science and Strategy of Sustained-Delivery TKIs
Ashkan Abbey, MD
Rishi Singh, MD, FASRS
Improving Early Detection of Geographic Atrophy
Alexandria May, PharmD, BCPS
Hasenin Al-khersan, MD
Extended Dosing Strategies for Diabetic Retinopathy and DME
Michael A. Klufas, MD
ILLUMIN-8: Real-World Outcomes with Aflibercept 8 Mg in DME
Optimizing Anti-VEGF Selection in Diabetic Macular Edema
Diagnostic Vitrectomy for Infectious Uveitis
Steven Yeh, MD, FASRS
Loading...
We're glad to see you're enjoying Eye Health Academy… but how about a more personalized experience?
Press cancel to remain on Eye Health Academy. Press the link below or the continue button to keep going.